- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Almirall (ALM)
The Almirall share price today is 10.840, view BME ALM stock exchange data. Track the latest Almirall share price with real-time updates on ALM stock performance including market cap, day range, 52-week range and dividend yield. Access ALM charts, earnings dates and analyst estimates to support your investment decisions.
10.840
-0.140(-1.28%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.800
11.020
52 wk Range
10.260
13.980
ALM is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.80011.020
52 wk Range
10.26013.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
14.508
Upside
+33.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
2 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.508
(+33.84% Upside)
Almirall Earnings Call Summary for Q2/2026
- Almirall H1 2026 revenue rose 7.5% to EUR 603M; EBITDA margin hit 25%, reaching 2028 target 2.5 years early; free cash flow improved to EUR 33M.
- Biologics drove growth: Ilumetri sales up 10.5% to EUR 125M, Ebglyss nearly doubled to EUR 85M; gross margin reached 64.6% amid portfolio optimization.
- Company reaffirmed FY 2026 guidance of 9-12% sales growth and EUR 270-290M EBITDA, expecting momentum to build progressively in H2.
- Management comfortable with Ilumetri consensus of EUR 260-262M and Ebglyss EUR 190-193M for 2026; EVOLVE PSO study for 200mg dose to start year-end.
- Key risks include Germany pricing reform, rising royalty tiers on Ilumetri, and increased R&D/SG&A spending expected to pressure margins later in year.
Last Updated: 24-07-2026, 02:32 pm
Read Full TranscriptEarnings
Latest Release
24-07-2026
EPS / Forecast
-- / 0.09
Revenue / Forecast
312M / 313.14M
Compare ALM to Peers and Sector
Metrics to compare | ALM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 39.9x | 16.0x | −0.4x | |
PEG Ratio | 0.22 | −0.10 | 0.00 | |
Price/Book | 1.5x | 5.0x | 2.6x | |
Price / LTM Sales | 2.0x | 3.1x | 3.1x | |
Upside (Analyst Target) | 32.4% | 23.9% | 48.8% | |
Fair Value Upside | Unlock | 20.5% | 5.7% | Unlock |
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations. It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage. It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Almirall (ALM) Share Price Today?
The Almirall share price today is 10.840.
What is the current Almirall (ALM) share price and day range?
As of 09-08-2026, the Almirall share price is 10.840, with a previous close of 10.840. The share price has ranged from 10.800 to 11.020 today, while the 52-week range spans from 10.260 to 13.980.
What Is the Almirall Market Cap?
As of today, Almirall market cap is 2.360B.
Does Almirall Pay Dividends? What's The Current Dividend Yield?
The Almirall dividend yield is 1.4%.
What Is the Almirall (ALM) Share Price Target?
The average 12-month share price target for Almirall is 14.508, with a high estimate of 17.5 and a low estimate of 12.5. 10 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +33.84% Upside potential.
What Is Almirall's Earnings Per Share (TTM)?
The Almirall EPS (TTM) is 0.276.
When Is the Next Almirall Earnings Date?
Almirall will release its next earnings report on 09-11-2026.
From a Technical Analysis Perspective, Is ALM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid Stock Exchange.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is "ALM."
How Many Times Has Almirall Stock Split?
Almirall has split 4 times.
How Many Employees Does Almirall Have?
Almirall has 2097 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.